AQR Arbitrage’s Globus Medical GMED Stock Holding History

AQR Arbitrage’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-8,112	Closed	-$522K	–	1136
2020 Q4	$522K	Buy	+8,112	New	+$466K	0.02%	638

Other funds holding GMED

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Axa Paris, France $256M AUM 25.01% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

AQR Arbitrage's GMED Position: Q1 2021 in Review

AQR Arbitrage sold out of Globus Medical (GMED) in Q1 2021, closing a stake of 8,112 shares — an estimated $522K sold.

AQR Arbitrage first reported a position in GMED in Q4 2020 and held it in 1 quarter. The position peaked at $522K in Q4 2020. 345 funds tracked by Wall St. Rank hold GMED as of Q1 2021.

AQR Arbitrage reported no remaining Globus Medical position as of Q1 2021 after selling out during the quarter.
AQR Arbitrage sold 8,112 Globus Medical shares in Q1 2021, an estimated $522K.
AQR Arbitrage first reported a position in Globus Medical in Q4 2020 and held it in 1 quarter.
AQR Arbitrage's Globus Medical position peaked at $522K in Q4 2020.
345 funds tracked by Wall St. Rank held Globus Medical as of Q1 2021.

Based on AQR Arbitrage's 13F filing for Q1 2021, filed 17 May 2021.